STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDCX
  4. [ARS] Medicus Pharma Ltd. SEC Filing

[ARS] Medicus Pharma Ltd. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - Medicus Pharma Ltd.

ARS Filing - Medicus Pharma Ltd.

This filing is available as a PDF document.

Filing Type: ARS

Company: Medicus Pharma Ltd. (MDCX)

Acceptance Date: 2025-06-30T17:01:04.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Medicus Pharma Ltd

NASDAQ:MDCX

View MDCX Stock Overview →

MDCX Rankings

#6280 Ranked by Market Cap
N/A Ranked by Dividends

MDCX Latest News

Mar 26, 2026
Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
Mar 25, 2026
Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update
Mar 18, 2026
Medicus Pharma To Discuss Positive Skinject(R) Phase 2 Topline Results In Fireside Chat Hosted By Brookline Capital Markets Biotechnology Equity Research Analyst
Mar 16, 2026
Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26
Mar 10, 2026
Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum

MDCX Latest SEC Filings

Mar 25, 2026
[POS AM] Medicus Pharma Ltd. SEC Filing
Mar 25, 2026
[POS AM] Medicus Pharma Ltd. SEC Filing
Mar 25, 2026
[POS AM] Medicus Pharma Ltd. SEC Filing
Mar 25, 2026
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 25, 2026
[424B3] Medicus Pharma Ltd. Prospectus Filed Pursuant to Rule 424(b)(3)

MDCX Stock Data

13.85M
17.84M
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
W. CONSHOHOCKEN